Yayınlar & Eserler

Yayın Ağı
Makaleler 81
Tümü (81)
SCI-E, SSCI, AHCI (71)
SCI-E, SSCI, AHCI, ESCI (77)
ESCI (6)
Scopus (76)
TRDizin (9)
Diğer Yayınlar (3)

1. Editorial: Emerging practices in therapeutic targeting of neurodegenerative diseases by modulating protein kinases

Hassan M., SEVER B.
Brain Research , cilt.1867, 2025 (SCI-Expanded, Scopus) identifier identifier

2. Targeting leukemic stem cells: enhanced eradication via tivantinib (ARQ197) and asciminib (ABL001) with molecular docking-guided screening of therapeutic derivatives

Karatekin Arik I., Gumus N., Alcitepe I., Gunduz C., SEVER B., Ciftci H. I., et al.
JOURNAL OF CHEMOTHERAPY , 2025 (SCI-Expanded, Scopus) identifier identifier identifier

3. Design, Synthesis, and Anticancer Evaluation of New Small-Molecule EGFR Inhibitors Targeting NSCLC and Breast Cancer

SEVER B., Otsuka M., Fujita M., Ciftci H.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.26, sa.15, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

4. Assessment of the anticancer function of Coronilla orientalis MILLER through comprehensive in vitro and computational studies

Ciftci H., ORAL A., COŞKUN Y., RENDA G., Otsuka M., Fujita M., et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , 2025 (SCI-Expanded, Scopus) identifier

5. Structure and Dynamics of the ABL1 Tyrosine Kinase and Its Important Role in Chronic Myeloid Leukemia

Irgit A., Kamıs R., SEVER B., TUYUN A. F., Otsuka M., Fujita M., et al.
Archiv der Pharmazie , cilt.358, sa.5, 2025 (SCI-Expanded, Scopus) identifier identifier

6. Structural Insights into the Dynamics of Water in SOD1 Catalysis and Drug Interactions

Yapici I., Tokur A. G., SEVER B., Ciftci H., Basak A. N., DeMirci H.
International Journal of Molecular Sciences , cilt.26, sa.9, 2025 (SCI-Expanded, Scopus) identifier identifier

7. A Structural Insight Into Two Important ErbB Receptors (EGFR and HER2) and Their Relevance to Non-Small Cell Lung Cancer

Topalan E., Buyukgungor A., Cigdem M., Gura S., SEVER B., Otsuka M., et al.
ARCHIV DER PHARMAZIE , sa.4, 2025 (SCI-Expanded, Scopus) identifier identifier

8. Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds

Reymova F., SEVER B., Topalan E., Sevimli-Gur C., Can M., TUYUN A. F., et al.
PHARMACEUTICALS , sa.2, 2025 (SCI-Expanded, Scopus) identifier identifier

9. Insights into therapeutic discovery through the Kelch domain structure of Keap1 at ambient temperature

Yilmaz M., Sever B., Kutlu Y., Gul M., Okuducu C., Tavli S., et al.
TURKISH JOURNAL OF BIOLOGY , cilt.49, sa.3, 2025 (SCI-Expanded, Scopus, TRDizin) identifier

10. A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication

SEVER B., Otsuka M., Fujita M., Ciftci H.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.25, sa.7, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

11. Scaffold Hopping and Structural Modification of NSC 663284: Discovery of Potent (Non)Halogenated Aminobenzoquinones

Bayrak N., Sever B., Ciftci H., Otsuka M., Fujita M., Tuyun A. F.
BIOMEDICINES , cilt.12, sa.1, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

12. Discovery of the Aminated Quinoxalines as Potential Active Molecules

Bener S., Bayrak N., Mataraci-Kara E., YILDIZ M., SEVER B., Ciftci H., et al.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.21, sa.15, ss.3285-3297, 2024 (SCI-Expanded, Scopus) identifier identifier

13. New naphthalene-linked pyrazoline-thiazole hybrids as prominent antilung and antibreast cancer inhibitors

Ciftci H., Otsuka M., Fujita M., Sever B.
TURKISH JOURNAL OF CHEMISTRY , cilt.48, sa.6, ss.856-866, 2024 (SCI-Expanded, Scopus, TRDizin) identifier identifier

14. Editorial: Multi-targeted tyrosine kinase inhibitors in the treatment of cancer and neurodegenerative disorders

SEVER B., Saso L., Tzoneva R., Onnis V., Ciftci H.
FRONTIERS IN CHEMISTRY , cilt.12, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

15. Structural Characterization of TRAF6 N-Terminal for Therapeutic Uses and Computational Studies on New Derivatives

Guven O., Sever B., Basoglu-Unal F., Ece A., Tateishi H., Koga R., et al.
PHARMACEUTICALS , cilt.16, sa.11, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

16. Evaluation of anti-glioma effects of benzothiazoles as efficient apoptosis inducers and DNA cleaving agents

SEVER B., Ciftci H.
MOLECULAR AND CELLULAR BIOCHEMISTRY , cilt.478, sa.5, ss.1099-1108, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

17. Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents

Kucukoglu K., Faydali N., Bul D., NADAROĞLU H., SEVER B., ALTINTOP M. D., et al.
Journal of Molecular Structure , cilt.1276, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

18. In vitro evaluation of 2-pyrazoline derivatives as DPP-4 inhibitors

Temel H. E., Altıntop M. D., Sever B., Özdemir A., Akalın Çiftçi G.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.48, sa.1, ss.104-109, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

19. Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-Colorectal and Anti-Breast Cancer Effects

Ciftci H., SEVER B., Kaya N., BAYRAK N., Yıldız M., YILDIRIM H., et al.
Molecules , cilt.28, sa.1, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

20. Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer

Altıntop M. D., Özdemir A., Temel H. E., Cevizlidere B. D., Sever B., Kaplancıklı Z. A., et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.244, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

21. Design, semi-synthesis and examination of new gypsogenin derivatives against leukemia via Abl tyrosine kinase inhibition and apoptosis induction

Ulusoy N. G., EMİRDAĞ S., Sozer E., Radwan M. O., Ciftci H., AKSEL M., et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , cilt.222, ss.1487-1499, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

22. In Vitro Cytotoxicity Evaluation of Plastoquinone Analogues against Colorectal and Breast Cancers along with In Silico Insights

Ciftci H., SEVER B., Bayrak N., Tateishi H., Otsuka M., Fujita M., et al.
PHARMACEUTICALS , cilt.15, sa.10, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

23. Identification of New L-Heptanoylphosphatidyl Inositol Pentakisphosphate Derivatives Targeting the Interaction with HIV-1 Gag by Molecular Modelling Studies

Ciftci H., SEVER B., Ayan E., Can M., DeMirci H., Otsuka M., et al.
PHARMACEUTICALS , cilt.15, sa.10, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

24. An investigation of bacteriocin nisin anti-cancer effects and FZD7 protein interactions in liver cancer cells

BALÇIK ERÇİN P., SEVER B.
CHEMICO-BIOLOGICAL INTERACTIONS , cilt.366, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

25. A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition

ALTINTOP M. D., SEVER B., AKALIN ÇİFTÇİ G., Ertorun I., Alastas O., ÖZDEMİR A.
ARCHIV DER PHARMAZIE , cilt.355, sa.9, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

26. Design, Synthesis and In vitro COX Inhibitory Profiles of A New Series of Tetrazole-based Hydrazones

ALTINTOP M. D., SEVER B., TEMEL H. E., KAPLANCIKLI Z. A., ÖZDEMİR A.
European Journal of Life Sciences , cilt.1, sa.1, ss.20-27, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma

27. Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis

SEVER B., Ciftci H., DeMirci H., Sever H., Ocak F., Yulug B., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.23, sa.5, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

28. In Vitro and In Silico Study of Analogs of Plant Product Plastoquinone to Be Effective in Colorectal Cancer Treatment

Ciftci H., SEVER B., Ocak F., Bayrak N., YILDIZ M., YILDIRIM H., et al.
MOLECULES , cilt.27, sa.3, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

29. A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy

ÖZDEMİR A., Ciftci H., SEVER B., Tateishi H., Otsuka M., Fujita M., et al.
MOLECULES , cilt.27, sa.2, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

30. Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds

SEVER B., TÜRKEŞ C., ALTINTOP M. D., Demir Y., AKALIN ÇİFTÇİ G., BEYDEMİR Ş.
ARCHIV DER PHARMAZIE , cilt.354, sa.12, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

31. EGFR-Targeted Pentacyclic Triterpene Analogues for Glioma Therapy

Ciftci H. I., Radwan M. O., SEVER B., Hamdy A. K., EMİRDAĞ S., Ulusoy N. G., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.22, sa.20, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

32. Design, synthesis and investigation of the mechanism of action underlying anti-leukemic effects of the quinolinequinones as LY83583 analogs

Ciftci H., BAYRAK N., YILDIZ M., YILDIRIM H., SEVER B., Tateishi H., et al.
BIOORGANIC CHEMISTRY , cilt.114, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

33. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines

SEVER B., ALTINTOP M. D., Demir Y., Yilmaz N., AKALIN ÇİFTÇİ G., BEYDEMİR Ş., et al.
CHEMICO-BIOLOGICAL INTERACTIONS , cilt.345, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

34. Structure based design, synthesis, and evaluation of anti-CML activity of the quinolinequinones as LY83583 analogs

BAYRAK N., Ciftci H. I., YILDIZ M., YILDIRIM H., SEVER B., Tateishi H., et al.
CHEMICO-BIOLOGICAL INTERACTIONS , cilt.345, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

35. A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity

SEVER B., ALTINTOP M. D., Demir Y., TÜRKEŞ C., Ozbas K., AKALIN ÇİFTÇİ G., et al.
OPEN CHEMISTRY , cilt.19, sa.1, ss.347-357, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

36. Synthesis of New Bis-pyrazolines Endowed with Potent Antifungal Activity against Candida albicans and Aspergillus niger

SEVER B., ALTINTOP M. D., ÖZDEMİR A.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.18, sa.1, ss.3-15, 2021 (SCI-Expanded, Scopus) identifier identifier

37. An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives

SEVER B., ALTINTOP M. D., Demir Y., Pekdogan M., AKALIN ÇİFTÇİ G., BEYDEMİR Ş., et al.
JOURNAL OF MOLECULAR STRUCTURE , cilt.1224, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

38. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies

SEVER B., ALTINTOP M. D., AKALIN ÇİFTÇİ G., ÖZDEMİR A.
MEDICINAL CHEMISTRY , cilt.17, sa.10, ss.1104-1128, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

39. A new series of benzoxazole-based SIRT1 modulators for targeted therapy of non-small-cell lung cancer

SEVER B., AKALIN ÇİFTÇİ G., ALTINTOP M. D.
ARCHIV DER PHARMAZIE , cilt.354, sa.1, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

40. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors

Zeytun E., ALTINTOP M. D., SEVER B., ÖZDEMİR A., Ellakwa D. E., Ocak Z., et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , cilt.21, sa.9, ss.1099-1109, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

41. Thiazolyl-pyrazoline derivatives: In vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors

SEVER B., TÜRKEŞ C., ALTINTOP M. D., Demir Y., BEYDEMİR Ş.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , cilt.163, ss.1970-1988, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

42. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors

SEVER B., ALTINTOP M. D., ÖZDEMİR A., AKALIN ÇİFTÇİ G., Ellakwa D. E., Tateishi H., et al.
MOLECULES , cilt.25, sa.21, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

43. Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects

SEVER B., Soybir H., Gorgulu S., CANTÜRK Z., ALTINTOP M. D.
MOLECULES , cilt.25, sa.21, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

44. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds

SEVER B., ALTINTOP M. D., Demir Y., AKALIN ÇİFTÇİ G., BEYDEMİR Ş., ÖZDEMİR A.
BIOORGANIC CHEMISTRY , cilt.102, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

45. In vitro and in silico studies on AChE inhibitory effects of a series of donepezil-like arylidene indanones

SEVER B., ALTINTOP M. D., TEMEL H. E.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.45, sa.4, ss.359-363, 2020 (SCI-Expanded, Scopus, TRDizin) identifier identifier

46. Design, synthesis and biological evaluation of new bis(thiosemicarbazone) derivatives as potential targeted anticancer agents for non-small cell lung cancer

Sever B., Akalın Çiftçi G., Özdemir A., Altıntop M. D.
JOURNAL OF RESEARCH IN PHARMACY , cilt.24, sa.5, ss.670-680, 2020 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

47. A Series of Furan-based Hydrazones: Design, Synthesis, and Evaluation of Antimicrobial Activity, Cytotoxicity and Genotoxicity

ALTINTOP M. D., SEVER B., ATLI EKLİOĞLU Ö., BAYSAL M., Demirel R., ÖZDEMİR A.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.17, sa.3, ss.312-322, 2020 (SCI-Expanded, Scopus) identifier identifier

48. In vitro and in silico assessment of antiproliferative activity of new acetamides bearing 1,3,4-oxadiazole and pyrimidine cores via COX inhibition

SEVER B., ALTINTOP M. D., AKALIN ÇİFTÇİ G.
JOURNAL OF RESEARCH IN PHARMACY , cilt.24, sa.5, ss.656-669, 2020 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

49. Design, Synthesis, In vitro and In silico Evaluation of New Hydrazone-based Antitumor Agents as Potent Akt Inhibitors

Gungor E. M., ALTINTOP M. D., SEVER B., AKALIN ÇİFTÇİ G.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.17, sa.11, ss.1380-1392, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

50. Investigation of the inhibitory effects of isoindoline-1,3-dion derivatives on hCA-I and hCA-II enzyme activities

NADAROĞLU H., Gungor A. A., GÜNDOĞDU Ö., KİSHALI N., SEVER B., ALTINTOP M. D.
JOURNAL OF MOLECULAR STRUCTURE , cilt.1197, ss.386-392, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

51. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors

Sever B., Altıntop M. D., Radwan M. O., Özdemir A., Otsuka M., Fujita M., et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.182, 2019 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

52. A Comprehensive Study on Thiadiazole-Based Anticancer Agents Inducing Cell Cycle Arrest and Apoptosis/Necrosis Through Suppression of Akt Activity in Lung Adenocarcinoma and Glioma Cells

AKALIN ÇİFTÇİ G., SEVER B., ALTINTOP M. D.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.16, sa.2, ss.119-131, 2019 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier identifier

53. Comprehensive Study on Thiadiazole-Based Anticancer İnducing Cell Cycle Arrest and Apoptosis/Necrosis Through Suppression of Akt Activity in Lung Adenocarcinoma and Glioma Cells

AKALIN ÇİFTÇİ G., SEVER B., ALTINTOP M. D.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.16, sa.2, ss.119-131, 2019 (Scopus, TRDizin) identifier identifier

54. Design, synthesis and in vitro evaluation of new thiosemicarbazone derivatives as potential anticancer agents

Sever B., Akalın Çiftçi G., Özdemir A., Altıntop M. D.
JOURNAL OF RESEARCH IN PHARMACY , cilt.23, sa.1, ss.16-24, 2019 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

55. New Benzodioxole-based Pyrazoline Derivatives: Synthesis and Anticandidal, In silico ADME, Molecular Docking Studies

ÖZDEMİR A., SEVER B., ALTINTOP M. D.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.16, sa.1, ss.82-92, 2019 (SCI-Expanded, Scopus) identifier identifier

56. In silico Molecular Docking and ADME Studies of 1 3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity

SEVER B., KÜÇÜKOĞLU K., NADAROĞLU H., ALTINTOP M. D.
CURRENT COMPUTER-AIDED DRUG DESIGN , cilt.15, sa.2, ss.136-144, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

57. Biological evaluation of a series of benzothiazole derivatives as mosquitocidal agents

SEVER B., ALTINTOP M. D., ÖZDEMİR A., Tabanca N., Estep A. S., Becnel J. J., et al.
OPEN CHEMISTRY , cilt.17, sa.1, ss.288-294, 2019 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

58. Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress

ÖZDEMİR A., SEVER B., ALTINTOP M. D., KAYA TİLKİ E., DİKMEN M.
MOLECULES , cilt.23, sa.9, 2018 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

59. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors

Altıntop M. D., Sever B., Akalın Çiftçi G., Turan-Zitouni G., Kaplancıklı Z. A., Özdemir A.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.155, ss.905-924, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

60. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors

ALTINTOP M. D., SEVER B., OSMANİYE D., SAĞLIK B. N., ÖZDEMİR A.
ARCHIV DER PHARMAZIE , cilt.351, sa.7, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

61. Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors

ALTINTOP M. D., SEVER B., AKALIN ÇİFTÇİ G., ÖZDEMİR A.
MOLECULES , cilt.23, sa.6, 2018 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

62. Synthesis and Biological Evaluation of New Quinoline-Based Thiazolyl Hydrazone Derivatives as Potent Antifungal and Anticancer Agents

Erguc A., ALTINTOP M. D., ATLI EKLİOĞLU Ö., SEVER B., İŞCAN G., Gormus G., et al.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.15, sa.2, ss.193-202, 2018 (SCI-Expanded, Scopus) identifier identifier

63. Synthesis and Evaluation of a New Series of Arylidene Indanones as Potential Anticancer Agents

ÖZDEMİR A., Gokbulut S., SEVER B., AKALIN ÇİFTÇİ G., ALTINTOP M. D.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , cilt.18, sa.10, ss.1394-1404, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

64. Antiproliferative Effects of a Series of Pyrazolines on Lung Cancer

SEVER B., ALTINTOP M. D., KAYA TİLKİ E., DİKMEN M., ÖZDEMİR A.
PROCEEDINGS (MDPI) , cilt.2, sa.25, ss.1574, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

65. Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety

Altıntop M. D., Ciftci H. I., Radwan M. O., Sever B., Kaplancıklı Z. A., Ali T. F. S., et al.
MOLECULES , cilt.23, sa.1, 2018 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

66. Synthesis of New Thiazolyl-pyrazoline Derivatives and Evaluation of Their Antimicrobial, Cytotoxic and Genotoxic Effects

SEVER B., ALTINTOP M. D., Gencer H., KAPKAÇ H. A., ATLI EKLİOĞLU Ö., BAYSAL M., et al.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.15, sa.7, ss.744-756, 2018 (SCI-Expanded, Scopus) identifier identifier

67. Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents

ALTINTOP M. D., SEVER B., ÖZDEMİR A., ILGIN S., ATLI EKLİOĞLU Ö., Turan-Zitouni G., et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , cilt.18, sa.11, ss.1606-1616, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

68. A New Series of Pyrrole-Based Chalcones: Synthesis and Evaluation of Antimicrobial Activity, Cytotoxicity, and Genotoxicity

ÖZDEMİR A., ALTINTOP M. D., SEVER B., Gencer H., KAPKAÇ H. A., ATLI EKLİOĞLU Ö., et al.
MOLECULES , cilt.22, sa.12, 2017 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

69. Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives

ALTINTOP M. D., SEVER B., ÖZDEMİR A., KÜÇÜKOĞLU K., Onem H., NADAROĞLU H., et al.
BIOORGANIC & MEDICINAL CHEMISTRY , cilt.25, sa.13, ss.3547-3554, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

70. Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9

ÖZDEMİR A., SEVER B., ALTINTOP M. D., TEMEL H. E., ATLI EKLİOĞLU Ö., BAYSAL M., et al.
MOLECULES , cilt.22, sa.7, 2017 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

71. Synthesis and evaluation of new benzodioxole-based dithiocarbamate derivatives as potential anticancer agents and hCA-I and hCA-II inhibitors

Altıntop M. D., Sever B., Akalın Çiftçi G., Kucukoglu K., Özdemir A., Soleimani S. S., et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.125, ss.190-196, 2017 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

72. Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors

KAPLANCIKLI Z. A., ALTINTOP M. D., ATLI EKLİOĞLU Ö., SEVER B., BAYSAL M., TEMEL H. E., et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , cilt.17, sa.5, ss.674-681, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

73. Synthesis and Evaluation of New Thiazolyl Hydrazone Derivatives as Potential Anticancer Agents

KAPLANCIKLI Z. A., SEVER B., ALTINTOP M. D., ATLI EKLİOĞLU Ö., BAYSAL M., ÖZDEMİR A.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.14, sa.6, ss.672-677, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

74. Synthesis and Evaluation of New Benzodioxole-Based Thiosemicarbazone Derivatives as Potential Antitumor Agents

ALTINTOP M. D., TEMEL H. E., SEVER B., AKALIN ÇİFTÇİ G., KAPLANCIKLI Z. A.
MOLECULES , cilt.21, sa.11, 2016 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

75. Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells

ALTINTOP M. D., SEVER B., ÖZDEMİR A., Kus G., Oztopcu-Vatan P., KABADERE S., et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , cilt.31, sa.3, ss.410-416, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

76. Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies

SEVER B., ALTINTOP M. D., KUŞ G., ÖZKURT M., ÖZDEMİR A., KAPLANCIKLI Z. A.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.113, ss.179-186, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

77. Synthesis and In Vitro Evaluation of New Thiosemicarbazone Derivatives as Potential Antimicrobial Agents

KAPLANCIKLI Z. A., ALTINTOP M. D., SEVER B., CANTÜRK Z., ÖZDEMİR A.
JOURNAL OF CHEMISTRY , cilt.2016, 2016 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

78. A Survey about Pharmacy Technicians in Eskisehir

ÖZDEMİR A., ALTINTOP M. D., SEVER B.
CUKUROVA MEDICAL JOURNAL , cilt.40, sa.4, ss.670-691, 2015 (ESCI, TRDizin) identifier

79. SYNTHESIS AND EVALUATION OF BENZODIOXOLE APPENDED PYRAZOLINE DERIVATIVES AS NEW ANTIMICROBIAL AGENTS

ALTINTOP M. D., SEVER B., ÖZDEMİR A., KAPLANCIKLI Z. A.
Anadolu Üniversitesi Bilim ve Teknoloji Dergisi :C-Yaşam Bilimleri ve Biyoteknoloji , cilt.4, sa.1, ss.1-11, 2015 (Hakemli Dergi)

80. Synthesis and Evaluation of Tetrazole-Based Hydrazone Derivatives Bearing a Pyridine Moiety as Antimicrobial Agents

ÖZDEMİR A., ALTINTOP M. D., SEVER B., CANTÜRK Z., KAPLANCIKLI Z. A.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.12, sa.8, ss.687-693, 2015 (SCI-Expanded, Scopus) identifier identifier

81. Study on thiazolyl-hydrazone derivatives as acetylcholinesterase inhibitors

ÖZKAY Y., YURTTAŞ L., Abu Mohsen U., SEVER B., Hussein W., Ozturk O., et al.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.4, sa.1, ss.38-42, 2014 (ESCI) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 114

1. Development of Chitosan-Fe3O4-Coated New L-HIPPO Derivatives to be effective against HIV-1/AIDS

DEMİR N., SEVER B., OTSUKA M., FUJITA M., CAN M., ÇİFTÇİ H.
VII. Ulusal Farmasötik Kimya Kongresi, İzmir, Türkiye, 26 Ekim 2024, (Özet Bildiri)

2. Design, synthesis and investigation of new oleanolic acid derivatives as potent Abl-based anti-CML agents

DEMİR N., SEVER B., OTSUKA M., FUJITA M., CAN M., ÇİFTÇİ H.
VII. Ulusal Farmasötik Kimya Kongresi, İzmir, Türkiye, 26 Ekim 2024, (Özet Bildiri)

3. Structural Insight Into ABL-1 and Its Interaction with Novel Inhibitors

IRGİT A., SEVER B., DEMİRCİ H., ÇİFTÇİ H.
7th International Joint Science Congress of Materials and Polymers (ISCMP), Gaziantep, Türkiye, 10 Ekim 2024, (Özet Bildiri)

4. Exploration of Anticancer Potential of Scrophularia nodosa (L.) with Mechanistic Insight

IRGİT A., SEVER B., ORAL A., COŞKUN Y., ÇİFTÇİ H.
7th International Joint Science Congress of Materials and Polymers (ISCMP), Gaziantep, Türkiye, 10 Ekim 2024, (Özet Bildiri)

5. Development of new dihydropyrazole derivatives as potent anticancer agents against NSCLC and breast carcinoma

ATAK F. B., SEVER B., OTSUKA M., FUJITA M., ÇİFTÇİ H.
7th International Eurasian Conference on Biological and Chemical Science, Ankara, Türkiye, 02 Ekim 2024, (Özet Bildiri)

6. Pyrimidine-Based New Thiazoles as Potential Anti-Lung Cancer Agents

ÇİFTÇİ H., SEVER B., ATAK F. B., TUYUN A. F., DEMİRCİ H., OTSUKA M., et al.
International Symposium on Medicinal and Useful Plants in Pharmaceutical and Biomedical Sciences between Japan - Nepal – Türkiye –Italy, Kumamoto, Japonya, 01 Haziran 2024, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Design, Synthesis and Structural Studies on New Anti-HIV Compounds Based on a Plant Product Phytic Acid

SEVER B., ÇİFTÇİ H.
International Symposium on Medicinal and Useful Plants in Pharmaceutical and Biomedical Sciences between Japan - Nepal – Türkiye –Italy, Kumamoto, Japonya, 1 - 02 Haziran 2024, (Özet Bildiri) Sürdürülebilir Kalkınma

8. Design, Synthesis and In Vitro Determination of Anticancer Effects of New Naphthalene Bearing Pyrazoline Compounds

SEVER B., OTSUKA M., FUJITA M., ÇİFTÇİ H.
International Symposium on Medicinal and Useful Plants in Pharmaceutical and Biomedical Sciences between Japan - Nepal – Türkiye –Italy, Kumamoto, Japonya, 01 Haziran 2024, (Özet Bildiri)

9. A new series of EGFR-targeted antitumor agents against non-small cell lung cancer

ÖZDEMİR A., SEVER B., ALTINTOP M. D., H T., M O., M F., et al.
A new series of EGFR-targeted antitumor agents against non-small cell lung cancer, Burdur, Türkiye, 29 Eylül 2021, (Özet Bildiri) Sürdürülebilir Kalkınma

10. New Imidazothiazole-Hydrazone Hybrids as Potent EGFR-Targeted Anticancer Agents

ALTINTOP M. D., SEVER B., H.İ. Ç., H T., M O., M F., et al.
V. International Joint Science Congress of Materials and Polymers (ISCMP), Burdur, Türkiye, 29 Eylül 2021, (Özet Bildiri)

11. Pyrazoline derivatives as anti-glioma agents

ÇİFTÇİ H., SEVER B.
V. International Joint Science Congress of Materials and Polymers (ISCMP), Burdur, Türkiye, 29 Eylül - 01 Ekim 2021, (Özet Bildiri)

12. Examining pharmacodynamic and pharmacokinetic properties of L-HIPPO for HIV treatment

SEVER B., ÇİFTÇİ H., TATEISHI H., OTSUKA M., FUJITA M., DEMİRCİ H.
V. International Joint Science Congress of Materials and Polymers (ISCMP), Burdur, Türkiye, 29 Eylül - 01 Ekim 2021, (Özet Bildiri) Sürdürülebilir Kalkınma

13. Determination of anticancer effects of 1,3,4-oxadiazole derivatives against glioblastoma multiforme

SEVER B., ÇİFTÇİ H.
V. International Joint Science Congress of Materials and Polymers (ISCMP), Burdur, Türkiye, 29 Eylül - 01 Ekim 2021, (Özet Bildiri)

14. Microwave-assisted Synthesis of A New Series of Pyrazolines Endowed with Potent Aldose Reductase Inhibitory Activity

SEVER B., ALTINTOP M. D., DEMİR Y., BEYDEMİR Ş., ÖZDEMİR A.
9. International Drug Chemistry Conference, Antalya, Türkiye, 08 Nisan 2021, (Özet Bildiri)

15. A New Series of Thiosemicarbazides Endowed with Potent COX Inhibitory Activity

Altıntop M. D., Sever B., Akalın Çiftçi G., Ertorun İ., Alataş İ. Ö.
9th Drug Chemistry Conference, Antalya, Türkiye, 8 - 11 Nisan 2021, (Özet Bildiri)

16. Anti-inflammatory effects of a new series of 6-arylidene-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-5-ones

Akalın Çiftçi G., Temel H. E., Altıntop M. D., Sever B., Huda M., Demir B., et al.
XXXI. Türk Biyokimya Derneği Ulusal Biyokimya Kongresi, 18 Aralık 2020, (Özet Bildiri)

17. A new series of chalcones as potent cathepsin D and L inhibitors

Temel H. E., Akalın Çiftçi G., Altıntop M. D., Sever B., Özdemir A.
XXXI. Türk Biyokimya Derneği Ulusal Biyokimya Kongresi, 18 Aralık 2020, (Özet Bildiri)

18. The Effects of a New Series of Phenothiazine-Based Hydrazones on Probiotic Microorganisms

ÇİMİK A., SEVER B., ALTINTOP M. D., ÖZDEMİR A.
32. Ulusal Kimya Kongresi (Online), Türkiye, 17 - 19 Eylül 2020, (Özet Bildiri)

19. A New Series of Thiazole-Based ABL1 Kinase Inhibitors as Antitumor Agents against Chronic Myelogenous Leukemia

ÖZDEMİR A., ALTINTOP M. D., SEVER B., Ciftci H. İ., Radwan M. O., Otsuka M., et al.
8. International Drug Chemistry Conference, Türkiye, 27 Şubat - 01 Mart 2020, (Özet Bildiri)

20. Synthesis, In vitro and In silico Evaluation of A Series of Pyrazolines as New DPP-4 Inhibitors.

ÖZDEMİR A., ALTINTOP M. D., SEVER B., TEMEL H. E.
8. International Drug Chemistry Conference, Türkiye, 27 Şubat - 01 Mart 2020, (Özet Bildiri)

21. New 1,3,4-oxadiazole derivatives as apoptosis inducers and EGFR inhibitors

SEVER B.
Virtual Meeting on DRUG DISCOVERY DEVELOPMENT AND LEAD OPTIMIZATION, Online, Amerika Birleşik Devletleri, 5 - 07 Ekim 2020, (Özet Bildiri)

22. Determination of Anticolorectal Cancer Effects of New Imidazole-Based Thiazolyl Hydrazone Derivatives

ORAL K., SEVER B., ALTINTOP M. D., CANTÜRK Z.
8th Drug Chemistry Conference, Antalya, Türkiye, 27 Şubat - 01 Mart 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

23. Design, Synthesis and Aldose Reductase Inhibitory Activity of New Triazole Derivatives

SEVER B., ALTINTOP M. D., PEKDOĞAN M., BEYDEMİR Ş., DEMİR Y.
8th Drug Chemistry Conference, Antalya, Türkiye, 27 Şubat - 01 Mart 2020, (Özet Bildiri)

24. New Pyrazole-Based Thiosemicarbazone Derivatives as Anti-Breast Cancer Agents

SOYBİR H., SEVER B., ALTINTOP M. D., CANTÜRK Z.
8th Drug Chemistry Conference, Antalya, Türkiye, 27 Şubat - 01 Mart 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

25. Determination of Anticolorectal Cancer Effects of New Imidazole-Based Thiazolyl Hydrazone Derivatives

ORAL K., SEVER B., ALTINTOP M. D., CANTÜRK Z.
8. International Drug Chemistry Conference, Antalya, Türkiye, 27 Şubat - 01 Mart 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

26. Synthesis and Evaluation of A New Series of Tetrazole-Hydrazone Hybrids as Potential Cytotoxic Agents on PC-12 Cells

ÖZTÜRK R. B., SEVER B., CANTÜRK Z., ALTINTOP M. D.
8th Drug Chemistry Conference, Antalya, Türkiye, 27 Şubat - 01 Mart 2020, (Özet Bildiri)

27. Synthesis and Evaluation of A Series of Thiazole Derivatives as New Apoptotic Anticandidal Agents

YILMAZ N., TOK S. B., SEVER B., CANTÜRK Z., ALTINTOP M. D.
8. International Drug Chemistry Conference, Antalya, Türkiye, 27 Şubat - 01 Mart 2020, (Özet Bildiri)

28. Design, Synthesis and Evaluation of A New Series of Tetrazole-Hydrazone Hybrids as Potential Cytotoxic Agents on PC-12 Cells

ÖZTÜRK R. B., SEVER B., CANTÜRK Z., ALTINTOP M. D.
8. International Drug Chemistry Conference, Antalya, Türkiye, 27 Şubat - 01 Mart 2020, (Özet Bildiri)

29. Determination of The Mechanism of Action Underlying Anticancer Effects of New Triazolothiadiazine Derivatives

SEVER B.
Cell Death: Degeneration and Regeneration Symposium, İstanbul, Türkiye, 3 - 05 Ekim 2019, (Özet Bildiri)

30. Design, Synthesis and Biological Evaluation of A New Series of Hydrazones as Antitumor Agents

Altıntop M. D., Güngör E. M., Sever B., Akalın Çiftçi G.
Cell Death: Degeneration and Regeneration Symposium, İstanbul, Türkiye, 3 - 05 Ekim 2019, ss.54, (Özet Bildiri) Sürdürülebilir Kalkınma

31. In Silico Studies on A Series of Thiosemicarbazone-based COX Inhibitors

ALTINTOP M. D., SEVER B., ÖZDEMİR A.
55th International Conference on Medicinal Chemistry, Nantes-France, 3 - 05 Temmuz 2019, (Özet Bildiri)

32. In Silico Evaluation of A Series of Furan-based Hydrazones as Lanosterol 14α-Demethylase Inhibitors

ÖZDEMİR A., ALTINTOP M. D., SEVER B.
55th International Conference on Medicinal Chemistry, Nantes-France, 3 - 05 Temmuz 2019, (Özet Bildiri)

33. New Pyrazoline Derivatives Clubbed with Thiazole Scaffold as Anticancer Agents Targeting EGFR

SEVER B., ALTINTOP M. D., Radwan M. O., ÖZDEMİR A., Otsuka M., Fujita M., et al.
11th Joint Meeting on Medicinal Chemistry 2019, Prague-Czech Republic, 27 - 30 Haziran 2019, (Özet Bildiri)

34. In Vitro Evaluation of A New Series of Bis-Pyrazolines as Antifungal Agents

ÖZDEMİR A., SEVER B., ALTINTOP M. D.
11th Joint Meeting on Medicinal Chemistry 2019, Prague-Czech Republic, 27 - 30 Haziran 2019, (Özet Bildiri)

35. New Thiazolyl-Pyrazoline Derivatives as Antibacterial Agents

ÖZDEMİR A., ALTINTOP M. D., SEVER B., Bülbül E. F., Karadağ A.
ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

36. The Antimicrobial and Genotoxic Effects of A New Series of Quinoxaline-Based Hydrazones

Çimik A., SEVER B., ALTINTOP M. D., ÖZDEMİR A.
The 5th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-5), Cappadocia-Turkey, 26 - 28 Nisan 2019, (Özet Bildiri)

37. A New Series of Morpholine-Based Thiazolyl-Pyrazolines as Dual EGFR and HER2 Inhibitors

SEVER B., ALTINTOP M. D., Radwan M. O., ÖZDEMİR A., Otsuka M., Fujita M., et al.
The 5th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-5), Cappadocia-Turkey, 26 - 28 Nisan 2019, (Özet Bildiri)

38. In Vitro and In Vivo Evaluation of A New Series of Thiosemicarbazones as Potential Anti-Inflammatory Agents

ALTINTOP M. D., SEVER B., Ertorun İ., Alataş i. Ö., AKALIN ÇİFTÇİ G., ÖZDEMİR A.
The 5th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-5), Cappadocia-Turkey, 26 - 28 Nisan 2019, (Özet Bildiri)

39. Design, Synthesis and In Vitro Evaluation of New Triazolothiadiazine Derivatives as Potential Antitumor Agents

ÖZDEMİR A., ALTINTOP M. D., SEVER B., AKALIN ÇİFTÇİ G.
The 5th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-5), Cappadocia-Turkey, 26 - 28 Nisan 2019, (Özet Bildiri)

40. Antiproliferative Effects of a Series of Pyrazolines on Lung Cancer

SEVER B., ALTINTOP M. D., KAYA TİLKİ E., DİKMEN M., ÖZDEMİR A.
2nd International Cell Death Research Congress-Turkey (3rd Congress of Cell Death Research Society-TURKEY), Izmir-TURKEY, 1 - 04 Kasım 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

41. Inhibition Effect of Arylidene indanones Derivatives on Acetylcholinesterase Enzyme Activity

TEMEL H. E., SEVER B., ALTINTOP M. D., ÖZDEMİR A.
TBS International Biochemistry Congress, Mugla-TURKEY, 26 - 30 Ekim 2018, (Özet Bildiri)

42. Synthesis and Antioxidant Activities of A New Series of 1,3,4-Oxadiazole Derivatives

ÖZDEMİR A., ALTINTOP M. D., SEVER B.
XXII International Conference on Organic Synthesis – 22-ICOS, Florence-ITALY, 16 - 21 Eylül 2018, (Özet Bildiri)

43. Design, Synthesis and Evaluation of A New Series of Bis-Pyrazoline Derivatives as Potential Antioxidant Agents

ALTINTOP M. D., ÖZDEMİR A., SEVER B.
XXII International Conference on Organic Synthesis – 22-ICOS, Florence-ITALY, 16 - 21 Eylül 2018, (Özet Bildiri)

44. In Vitro and In Silico Studies on The Mosquitocidal Activity of A Series of Piperidine Derivatives against Aedes aegypti

ALTINTOP M. D., SEVER B., ÖZDEMİR A., Tabanca N., Estep A., Becnel J. J., et al.
Italian-Spanish-Portuguese Joint Meeting in Medicinal Chemistry MedChemSicily2018, Palermo-ITALY, 17 - 20 Temmuz 2018, (Özet Bildiri)

45. Synthesis and Neuroprotective Effects of New Pyrazoline Derivatives

ÖZDEMİR A., SEVER B., ALTINTOP M. D., KAYA TİLKİ E., DİKMEN M.
Italian-Spanish-Portuguese Joint Meeting in Medicinal Chemistry MedChemSicily2018, Palermo-ITALY, 17 - 20 Temmuz 2018, (Özet Bildiri)

46. Synthesis and In Vitro Studies of A New Series of Thiosemicarbazones as Anticancer Agents

SEVER B., ÖZDEMİR A., AKALIN ÇİFTÇİ G., ALTINTOP M. D.
Italian-Spanish-Portuguese Joint Meeting in Medicinal Chemistry MedChemSicily2018, Palermo-ITALY, 17 - 20 Temmuz 2018, (Özet Bildiri)

47. In vitro and in silico studies of a new series of benzazole-based anticancer agents targeting SIRT1

ALTINTOP M. D., SEVER B., AKALIN ÇİFTÇİ G.
MedChemSicily2018 Italian-Spanish-Portuguese Joint Meeting in Medicinal Chemistry, Palermo, İtalya, 17 - 20 Temmuz 2018, (Özet Bildiri)

48. Synthesis, In Vitro and In Silico Studies of A Series of Dithiocarbamate Derivatives as Anticandidal Agents

ÖZDEMİR A., Yılmaz N., SEVER B., ALTINTOP M. D.
ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

49. Synthesis, In Vitro and In Silico Studies of New Pyrazoline Derivatives as Potential Anticandidal Agents

ÖZDEMİR A., ALTINTOP M. D., SEVER B.
ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

50. New Thiazole Derivatives as Potential Aldose Reductase Inhibitors

SEVER B., ALTINTOP M. D., BEYDEMİR Ş., Demir Y., ÖZDEMİR A.
ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

51. Synthesis and Evaluation of New Pyrazoline Derivatives as Antibacterial Agents

ÖZDEMİR A., ALTINTOP M. D., SEVER B., Bülbül E. F., Karadağ A.
ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

52. Synthesis, In Vitro and In Silico Studies of A Series of 1,3,4-Oxadiazoles as FAK Inhibitors

ALTINTOP M. D., SEVER B., ÖZDEMİR A., AKALIN ÇİFTÇİ G.
ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

53. In Vitro and In Silico Studies of A Series of 1,3,4-Thiadiazoles as Acetylcholinesterase Inhibitors

ALTINTOP M. D., SEVER B., ÖZDEMİR A., Zeytun E., TEMEL H. E.
ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

54. Synthesis and Evaluation of New Benzazole Derivatives as Potential Anticandidal Agents

ÖZDEMİR A., ALTINTOP M. D., SEVER B.
ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

55. Neuroprotective Effects of Some Pyrazoline Derivatives Against 6-OHDA Induced Neurodegeneration

SEVER B., ALTINTOP M. D., ÖZDEMİR A., KAYA TİLKİ E., DİKMEN M.
ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

56. Synthesis and evaluation of a series of pyrazoline derivatives as potential neuroprotective agents

SEVER B., ALTINTOP M. D., KAYA TİLKİ E., DİKMEN M., ÖZDEMİR A.
the 4rd International Conference on Applied Biological Sciences (ICABS 2018), Eskişehir, Türkiye, 3 - 05 Mayıs 2018, (Özet Bildiri)

57. Design, Synthesis, In Vitro and In Silico Evaluation of New Triazolothiadiazine Derivatives as Potential Dipeptidyl Peptidase-4 Inhibitors

YILMAZ N., SEVER B., TEMEL H. E., ALTINTOP M. D.
The 5th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-5), Nevşehir, Türkiye, 26 - 28 Nisan 2018, (Özet Bildiri)

58. Synthesis and Evaluation of New Benzothiazole Derivatives as Potential Anti-Breast Cancer Agents

SEVER B., ALTINTOP M. D., ILGIN S., ATLI Ö.
2nd International Gazi Pharma Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

59. Design, Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticandidal Agents

ALTINTOP M. D., SEVER B., ÖZDEMİR A.
5th International BAU Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

60. Synthesis and Evaluation of New Pyrrole Derivatives as Selective Human MAO Inhibitors

ÖZDEMİR A., ALTINTOP M. D., SEVER B.
5th International BAU Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

61. Design, Synthesis and Evaluation of New Oxadiazole Derivatives as Potential Akt Inhibitors

SEVER B., ALTINTOP M. D., AKALIN ÇİFTÇİ G., ÖZDEMİR A.
5th International BAU Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

62. Synthesis and Evaluation of A New Series of Donepezil-Like Chalcone Derivatives as Potential AChE Inhibitors

ALTINTOP M. D., SEVER B., TEMEL H. E., AKALIN ÇİFTÇİ G.
5th International BAU Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

63. Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticandidal Agents

ALTINTOP M. D., SEVER B., ÖZDEMİR A.
5th International BAU Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

64. Design, Synthesis and Evaluation of A New Series of Donepezil-Like Chalcone Derivatives as Potential AChE Inhibitors

ALTINTOP M. D., SEVER B., TEMEL H. E., AKALIN ÇİFTÇİ G.
5th International BAU-Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

65. Synthesis and Evaluation of A New Series of Naphthalene-Based Thiadiazole Derivatives as Potential Anticancer Agents

SEVER B., ALTINTOP M. D., ILGIN S., ATLI Ö.
5th International Bahçeşehir University (BAU) Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

66. Design, Synthesis and Evaluation of New Thiazolyl-Pyrazoline Derivatives as Potential Anticandidal Agents

BAYTEKİN G., ALTINTOP M. D., SEVER B., ÖZDEMİR A.
2nd International Gazi Pharma Symposium (2nd GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

67. Synthesis and Evaluation of New Thiazole Derivatives as Potential Anticancer Agents Targeting AKT

ALTINTOP M. D., SEVER B., AKALIN ÇİFTÇİ G., ÖZDEMİR A.
2nd International Gazi Pharma Symposium (2nd GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

68. PON1 aktivatörü tiyadiazol türevlerinin moleküler docking çalışmaları

SEVER B., ALTINTOP M. D.
. Anadolu Üniversitesi Eczacılık Sempozyumu (ANES), Eskişehir, Türkiye, 1 - 02 Haziran 2017, (Özet Bildiri)

69. Kinolin halkası taşıyan yeni tiyazolil-hidrazon türevlerinin antikandidal etkilerinin değerlendirilmesi

ERGÜÇ A., SEVER B., İŞCAN G., ATLI EKLİOĞLU Ö., GÖRMÜŞ G., ALTINTOP M. D.
1. Anadolu Üniversitesi Eczacılık Sempozyumu (ANES), Eskişehir, Türkiye, 1 - 02 Haziran 2017, (Özet Bildiri)

70. Pharmacy Students’ Perceptions on Pharmaceutical Promotion

ALTINTOP M. D., ÖZDEMİR A., SEVER B., EVREN A. E.
6th Pharmaceutical Sciences World Congress 2017 (FIP PSWC 2017), Stockholm, İsveç, 21 - 24 Mayıs 2017, (Özet Bildiri)

71. Synthesis and Evaluation of New Quinoline-Based Thiazole Derivatives as Potent Anticancer Agents

ALTINTOP M. D., ERGÜÇ A., SEVER B., ATLI Ö.
6th FIP Pharmaceutical Sciences World Congress 2017, Stockholm, İsveç, 21 - 24 Mayıs 2017, (Özet Bildiri)

72. Synthesis and Evaluation of Fluorobenzoxazole Based Hydrazone Derivatives as Novel Anticholinesterase Agents

TEMEL H. E., ALTINTOP M. D., SEVER B., AKALIN ÇİFTÇİ G.
IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

73. The Problems of Healthcare System in Turkey

SEVER B., ÖZDEMİR A., ALTINTOP M. D.
IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

74. A series of Pyrazoline Derivatives as Potent Anticandidal Agents

ÖZDEMİR A., ALTINTOP M. D., SEVER B., KARACA GENÇER H., ATLI EKLİOĞLU Ö.
IVEK, 26 - 29 Nisan 2017, (Özet Bildiri)

75. An Approach of Turkish Pharmaceutical Industry to Biotechnological and Biosimilar Drugs

SEVER B., ÖZDEMİR A., ALTINTOP M. D.
IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

76. Synthesis, Evaluation of New Chalcone Derivatives as Potential Anticholinesterase Agents and Docking Studies

SEVER B., ALTINTOP M. D., TEMEL H. E., ÖZDEMİR A.
IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

77. Eczacıların Farmakoinformatiği Kullanma Amaçları

ÖZDEMİR A., SEVER B., ALTINTOP M. D.
IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

78. Syntheis and Evaluation of Fluorobenzoxazole Based Hydrazone Derivativs as Novel Anticholinesterase Agents

TEMEL H. E., ALTINTOP M. D., SEVER B., AKALIN ÇİFTÇİ G.
3. İlaç ve Eczacılık Kongres 2017, 26 - 29 Nisan 2017, (Özet Bildiri)

79. The Problem of Healthcare System in Turkey

SEVER B., ÖZDEMİR A., ALTINTOP M. D.
IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

80. The Effects of New Azole Derivatives on MMP Enzymes and Their Roles in Alzheimer’s Disease

SEVER B., ALTINTOP M. D., TEMEL H. E., DEMİRCİ F.
13th International Conference on Alzheimer’xxs and Parkinson’xxs Diseases (ADPD 2017), ViİYANA, Avusturya, 29 Mart - 02 Nisan 2017, cilt.17, ss.926-1890, (Özet Bildiri) identifier identifier

81. Pirazolin türevlerinin antikandidal etkilerinin araştırılması

ALTINTOP M. D., SEVER B., İŞCAN G., ÖZDEMİR A.
13. Türkiye Eczacılık Kongresi, İstanbul, Türkiye, 21 - 24 Aralık 2016, (Özet Bildiri)

82. Synthesis and cytotoxic evaluation of new 1,3,4-thiadiazole derivatives as potential anticancer agents

ALTUĞ TASA B., ALTINTOP M. D., SEVER B., ÖZDEMİR A., KAPLANCIKLI Z. A., KOPARAL A. T.
6. Multidisipliner Kanser Araştırma Kongresi, Konya, Türkiye, 27 - 30 Ekim 2016, (Özet Bildiri)

83. Synthesis and Antimycobacterial Activity of 5-Arylfurfural N-(2,4 difluorophenyl)thiosemicarbazone Derivatives

Sever B., Altıntop M. D., Özdemir A.
4th International BAU-Drug Design Congress, İstanbul, Türkiye, 13 - 15 Ekim 2016, (Özet Bildiri)

84. Synthesis and Evaluation of 1,3,4-Thiadiazole Derivatives as Potential PON1 Activators

Sever B., Altıntop M. D.
4th International BAU Drug Design Congress, İstanbul, Türkiye, 13 - 15 Ekim 2016, (Özet Bildiri)

85. Synthesis of Novel Thiazole Derivatives and Evaluation of Their Cytotoxic Effects on A549 Cells

SEVER B., ALTINTOP M. D., AKALIN ÇİFTÇİ G., ÖZDEMİR A.
XXIV National Meeting on Medicinal Chemistry and 10th Young Medicinal Chemists’ Symposium, 11 - 14 Eylül 2016

86. Synthesis of Novel Thiosemicarbazone Derivatives and Evaluation of Their Antibacterial Activities

Sever B., Altıntop M. D., Kaplancıklı Z. A.
XXIV National Meeting in Medicinal Chemistry, Perugia, İtalya, 11 - 14 Eylül 2016, (Özet Bildiri)

87. Synthesis and evaluation of new benzodioxole derivatives as potential hCA I and hCA II inhibitors

ÖZDEMİR A., ALTINTOP M. D., SEVER B., KÜÇÜKOĞLU K., SOLEİMANİ S. S., NADAROĞLU H., et al.
17th Tetrahedron Symposium, 28 Haziran - 01 Temmuz 2016

88. Synthesis and evluation of new thiadiazole derivatives as potential carbonic anhydrase inhibitors

SEVER B., ALTINTOP M. D., ÖZDEMİR A., KÜÇÜKOĞLU K., önem h., NADAROĞLU H., et al.
Challenges in Biological, Bioorganic, organic and Medicinal Chemistry, 28 Haziran - 01 Temmuz 2016

89. Synthesis and evaluation of new thiosemicarbazone derivatives as potential COX inhibitors

ALTINTOP M. D., ÖZDEMİR A., SEVER B., AKALIN ÇİFTÇİ G., KAPLANCIKLI Z. A.
17th Tetrahedron Symposium, 28 Haziran - 01 Temmuz 2016

90. Synthesis and evaluation of new thiadiazole derivatives as potential carbonic anhydrase inhibitors

SEVER B., ALTINTOP M. D., ÖZDEMİR A., KÜÇÜKOĞLU K., ÖNEM H., NADAROĞLU H., et al.
17th Tetrahedron Symposium, 28 Haziran - 01 Temmuz 2016

91. Synthesis and evaluation of DNA İnhibitory Effects of Novel Thiosemicarbazone Derivatives

SEVER B., ALTINTOP M. D., AKALIN ÇİFTÇİ G., KAPLANCIKLI Z. A.
1th Cell Death Research Congress-Turkey, 4 - 07 Mayıs 2016

92. Oxadiazole Based Pyrazoline Derivatives as New Antitumor Agents

ÖZDEMİR A., ALTINTOP M. D., SEVER B., ATLI Ö., BAYSAL M., KAPLANCIKLI Z. A.
1st International Cell Death Research Congress, 4 - 07 Mayıs 2016

93. Synthesis and Evaluation of DNA Inhibitory Effects of Novel Thiosemicarbazone Derivatives

SEVER B., ALTINTOP M. D., AKALIN ÇİFTÇİ G., KAPLANCIKLI Z. A.
1st International Cell Death Research Congress, İzmir, Türkiye, 4 - 07 Mayıs 2016

94. Synthesis and Evaluatıon of DNA Inhibitory Effects of Novel Thiosemicarbazone Derivatives

Sever B., Altıntop M. D., Akalın Çiftçi G., Kaplancıklı Z. A.
1st International Cell Death Research Congress, İzmir, Türkiye, 4 - 07 Mayıs 2016, (Özet Bildiri)

95. The Pharmacies of Estonia up to 1940

SEVER B.
IVEK 2nd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 27 - 29 Kasım 2015, (Özet Bildiri)

96. Synthesis and cytotoxic effects of new benzodioxole derivatives on A549 and C6 cells

Altıntop M. D., Sever B., Akalın Çiftçi G.
IVEK 2nd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 27 - 29 Kasım 2015, (Özet Bildiri)

97. Drug research and ethics

SEVER B.
IVEK 2nd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 27 - 29 Kasım 2015, (Özet Bildiri)

98. Synthesis and in vitro effects of some thiazole derivatives on Helicobacter pylori

Sever B., Altıntop M. D., Demirci F.
IVEK 2nd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 27 - 29 Kasım 2015, (Özet Bildiri)

99. Synthesis of some benzodioxole derivatives as new anticholinesterase agents

Sever B., Altıntop M. D., Temel H. E., Kaplancıklı Z. A.
International Multidisciplinary Symposium on Drug Research Development DRD 2015, Eskişehir, Türkiye, 15 - 17 Ekim 2015, (Özet Bildiri)

100. Synthesis of Some Thiosemicarbazone Derivatives as New Antitubercular Agents

Sever B., Altıntop M. D., Cantürk Z., Kaplancıklı Z. A.
International Multidisciplinary Symposium on Drug Research & Development DRD 2015, Eskişehir, Türkiye, 15 - 17 Ekim 2015, (Özet Bildiri)

101. Synthesis and evaluation of some benzodioxole-based thiosemicarbazone derivatives as novel anticancer agents

Sever B., Altıntop M. D., Akalın Çiftçi G., Temel H. E., Kaplancıklı Z. A.
3rd International BAU Drug Design Congress, İstanbul, Türkiye, 1 - 03 Ekim 2015, (Özet Bildiri)

102. Synthesis of Some Triazolothiadiazine Derivatives as New LOX Inhibitors

Sever B., Altıntop M. D., Temel H. E., Kaplancıklı Z. A.
16th Blue Danube Symposium on Heterocyclic Chemistry, Veszprém, Macaristan, 14 - 17 Haziran 2015, (Özet Bildiri)

103. Synthesis and evaluation of triazolothiadiazine derivates as new anticancer agents related to COX-2 inhibition

Sever B., Altıntop M. D., Kuş G., Özkurt M., Kaplancıklı Z. A.
ISOPS 11th International symposium on pharmaceutical sciences, Ankara, Türkiye, 9 - 12 Haziran 2015, ss.40-41, (Özet Bildiri) Sürdürülebilir Kalkınma

104. Synthesis and Evaluation of Triazolothiadiazine Derivatives as New Anticancer Agents Related to COX 2 Inhibition

SEVER B., ALTINTOP M. D., KUŞ G., ÖZKURT M., KAPLANCIKLI Z. A.
ISOPS 11th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 9 - 12 Haziran 2015, (Özet Bildiri)

105. Thiazole Based Anticholinesterase Agents

SEVER B., ALTINTOP M. D., TEMEL H. E., ÖZDEMİR A.
XXIII National Meeting on Medicinal Chemistry, 6 - 09 Eylül 2015

106. Synthesis and in vitro effects of new thiosemicarbazone derivatives against LNCaP cancer cells

Sever B., Altıntop M. D., Kuş G., Öztopcu Vatan A. P., Kabadere S., Kaplancıklı Z. A.
V. INTERNATIONAL CONGRESS OF MOLECULAR MEDICINE, İzmir, Türkiye, 20 - 22 Mayıs 2015, ss.62, (Özet Bildiri)

107. Synthesis and In vitro effects of new thiosemicarbazone derivatives against LNCaP cancer cells

SEVER B., ALTINTOP M. D., KUŞ G., ÖZTOPCU VATAN A. P., KABADERE S., KAPLANCIKLI Z. A.
V. International Congress of Molecular Medicine, İzmir, Türkiye, 20 - 22 Mayıs 2015, (Özet Bildiri) Sürdürülebilir Kalkınma

108. Synthesis and Antimicrobial Activity of Tetrazole substituted Hydrazone Derivatives

ÖZDEMİR A., ALTINTOP M. D., SEVER B., KAPLANCIKLI Z. A.
5th International Congress of Molecular Medicine, İzmir, Türkiye, 20 - 22 Mayıs 2015

109. Synthesis and antimicrobial activity of tetrazole sustituted hydrazone derivatives

ÖZDEMİR A., ALTINTOP M. D., SEVER B., KAPLANCIKLI Z. A.
V. International Congres of Molecular Medicine, 20 - 22 Mayıs 2015

110. Parexel tarafından Londra’da Northwick Park hastanesinde yapılmış olan Faz I monoklonal antikor çalışmasının etik açıdan incelenmesi

SEVER B.
12. Türkiye Eczacılık Kongresi, Ankara, Türkiye, 25 - 27 Eylül 2014, (Özet Bildiri)

111. A Mini-survey on Pharmacy Technicians in Eskişehir

Özdemir A., Saydam E., Sever B., Altıntop M. D.
12. Türkiye Eczacılık Kongresi, Ankara, Türkiye, 25 - 27 Eylül 2014, (Özet Bildiri)

112. Pharmacy Technicians from the Perspective of Pharmacists in Eskişehir

Altıntop M. D., Saydam E., Sever B., Özdemir A.
12. Türkiye Eczacılık Kongresi, Ankara, Türkiye, 25 - 27 Eylül 2014, (Özet Bildiri)

113. Synthesis and evaluation of thiazole-based oxadiazole derivatives as potential anticancer agents

Özdemir A., Altıntop M. D., Turan G., Sever B., Akalın Çiftçi G., Kaplancıklı Z. A.
MCB2014 Joining forces in pharmaceutical analysis and medicinal chemistry, Groningen, Hollanda, 25 - 26 Ağustos 2014, (Özet Bildiri)

114. Synthesis of new thiazolyl hydrazone derivatives as potential anticancer agents

Sever B., Altıntop M. D., Ilgın S., Atlı Eklioğlu Ö., Kaplancıklı Z. A.
MCB2014 Joining forces in pharmaceutical analysis and medicinal chemistry, Groningen, Hollanda, 25 - 26 Ağustos 2014, (Özet Bildiri)
Kitaplar 24

1. Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders

Çiftçi H. (Editör), Sever B. (Editör), Saso L. (Editör), Tzoneva R. (Editör), Onnis V. (Editör)
Frontiers Media SA, Lausanne, 2024 Sürdürülebilir Kalkınma

2. Structural and Computational-Driven Molecule Design in Drug Discovery

Çiftçi H. (Editör), Sever B. (Editör), Demirci H. (Editör)
MDPI, Basel, 2024

3. Konu Çalışması 10: HCV NS3-4A proteazın geri dönüşümlü inhibitörleri

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.795-800, 2021

4. Konu Çalışması 2: ADE inhibitörlerinin tasarımı

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.302-308, 2021

5. Konu Çalışması 4: Oksamnikuin’in tasarımı

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, PROF. DR. ÖZTEKİN ALGÜL, Editör, Ankara Nobel Tıp Kitabevleri, ss.315-321, 2021

6. Konu Çalışması 6: Steroidal antiinflamatuvar ilaçlar

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, PROF. DR. ÖZTEKİN ALGÜL, Editör, Ankara Nobel Tıp Kitabevleri, ss.766-775, 2021

7. Konu Çalışması 1: Statinler

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.187-194, 2021

8. Konu Çalışması 10: HCV NS3-4A proteazın geri dönüşümlü inhibitörleri

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, PROF. DR. ÖZTEKİN ALGÜL, Editör, Ankara Nobel Tıp Kitabevleri, ss.795-800, 2021

9. Konu Çalışması 6: Steroidal antiinflamatuvar ilaçlar

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.766-775, 2021

10. Bölüm 8 (Sağlık İşletmelerinde Taciz, Mobbing, Şiddet)

SEVER B.
Sağlık İşletmelerinde Davranış, Prof. Dr. Ahmet Özdemir, Editör, Anadolu Üniversitesi Yayınları, Eskişehir, ss.214-242, 2021

11. Konu Çalışması 8: Aliskiren’in tasarımı ve geliştirilmesi

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, PROF. DR. ÖZTEKİN ALGÜL, Editör, Ankara Nobel Tıp Kitabevleri, ss.781-787, 2021

12. Konu Çalışması 2: ADE inhibitörlerinin tasarımı

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, PROF. DR. ÖZTEKİN ALGÜL, Editör, Ankara Nobel Tıp Kitabevleri, ss.302-308, 2021

13. Konu Çalışması 5: Bir timidilat sentaz inhibitörünün tasarlanması

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, PROF. DR. ÖZTEKİN ALGÜL, Editör, Ankara Nobel Tıp Kitabevleri, ss.419-422, 2021

14. Konu Çalışması 9: Faktör Xa inhibitörleri

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.788-794, 2021

15. Konu Çalışması 4: Oksamnikuin’in tasarımı

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.315-321, 2021

16. Konu Çalışması 5: Bir timidilat sentaz inhibitörünün tasarlanması

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.419-422, 2021

17. Konu Çalışması 8: Aliskiren’in tasarımı ve geliştirilmesi

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.781-787, 2021

18. Konu Çalışması 7: Antidepresanlar üzerine güncel bir çalışma

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, PROF. DR. ÖZTEKİN ALGÜL, Editör, Ankara Nobel Tıp Kitabevleri, ss.776-780, 2021

19. Konu Çalışması 1: Statinler

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, PROF. DR. ÖZTEKİN ALGÜL, Editör, Ankara Nobel Tıp Kitabevleri, ss.187-194, 2021

20. Konu Çalışması 9: Faktör Xa inhibitörleri

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, PROF. DR. ÖZTEKİN ALGÜL, Editör, Ankara Nobel Tıp Kitabevleri, ss.788-794, 2021

21. Konu Çalışması 7: Antidepresanlar üzerine güncel bir çalışma

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.776-780, 2021

22. Konu Çalışması 3: Artemisinin ve benzer antimalaryal ilaçlar

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, PROF. DR. ÖZTEKİN ALGÜL, Editör, Ankara Nobel Tıp Kitabevleri, ss.309-314, 2021

23. Konu Çalışması 3: Artemisinin ve benzer antimalaryal ilaçlar

ALTINTOP M. D., SEVER B.
Medisinal Kimya Giriş, Prof. Dr. Öztekin Algül, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.309-314, 2021

24. Bölüm 8 (Olağan Dışı Koşullarda İnsan Psikolojisi)

SEVER B.
Sağlık Kurumlarında Afet ve Kriz Yönetimi, Prof. Dr. Ahmet Özdemir, Editör, Anadolu Üniversitesi Yayınları, Eskişehir, ss.230-255, 2020
Metrikler

Yayın

220

Yayın (WoS)

77

Yayın (Scopus)

77

Atıf (WoS)

1575

H-İndeks (WoS)

25

Atıf (Scopus)

1656

H-İndeks (Scopus)

25

Atıf (Scholar)

1970

H-İndeks (Scholar)

27

Toplam Atıf Sayısı

1638

Proje

30

Fikri Mülkiyet

4

Tez Danışmanlığı

2

Açık Erişim

30
BM Sürdürülebilir Kalkınma Amaçları